share_log

Lake Street Initiates Coverage On LifeMD With Buy Rating, Announces Price Target of $12

Benzinga ·  Dec 10 10:51  · Ratings

Lake Street analyst Brooks O'Neil initiates coverage on LifeMD (NASDAQ:LFMD) with a Buy rating and announces Price Target of $12.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment